Push Admin

Philippines eyes portfolio of potential vaccines vs COVID-19

Article (news)

Davinci Maru, ABS-CBN News

<div class="embed-wrap"><figure data-feedback="fb:likes,fb:comments"><img src="http://sa.kapamilya.com/absnews/abscbnnews/media/2020/tvpatrol/11/25/vaccine.jpg"/><figcaption>A woman holds a small bottle labeled with a &quot;Coronavirus COVID-19 Vaccine&quot; sticker and a medical syringe in this illustration taken Oct. 30, 2020. Dado Ruvic, Reuters/File</figcaption></figure></div>MANILA - The Philippines is looking into building a portfolio of potential vaccines against the novel coronavirus, an official spearheading the country&#x27;s COVID-19 inoculation program said Friday.Vaccine czar Carlito Galvez, in an interview with Teleradyo, said they had been in advanced talks with various pharmaceutical companies over holding clinical trials of their experimental vaccines in the country.&quot;Ang gagawin natin is portfolio po. Kasi alam po natin there&#x27;s still uncertainties on the efficacy and safety [of the vaccines],&quot; he said.(We&#x27;re building a portfolio because we know there&#x27;s still uncertainties on the efficacy and safety [of the vaccines].)Other companies Philippines is negotiating with are China&#x27;s Sinovac, Russia&#x27;s state-run Gamaleya Institute and Johnson &amp; Johnson&#x27;s pharmaceuticals arm Janssen.Galvez said the Philippines was also set to sign a confidential agreement with US drug maker Pfizer for possible vaccine supply deal.Pfizer recently reported its vaccine was <a href="https://news.abs-cbn.com/news/11/18/20/pfizer-ends-covid-19-trial-with-95-efficacy-to-seek-emergency-use-authorization">95 percent effective</a> at preventing COVID-19 while AstraZeneca&#x27;s vaccine developed with the University of Oxford showed an average <a href="https://news.abs-cbn.com/overseas/11/24/20/easy-cheap-to-produce-astrazenecas-covid-vaccine-appears-effective">70-percent efficacy</a>.<ul class="op-related-articles">	<li><a href="https://news.abs-cbn.com/news/11/26/20/philippines-to-sign-deal-to-buy-2-million-covid-19-vaccine-doses-this-week">Philippines to sign deal to buy 2 million COVID-19 vaccine doses this week</a></li>	<li><a href="https://news.abs-cbn.com/overseas/11/27/20/astrazeneca-says-its-vaccine-needs-additional-study">AstraZeneca says its vaccine needs &#x27;additional study&#x27;</a></li></ul>The Philippines on Friday signed a deal with AstraZeneca for the purchase of 2 million possible coronavirus vaccines as part of the private sector&#x27;s initiative to boost the country&#x27;s fight against the disease.Private firms such as San Miguel, Aboitiz, Ayala, JG Summit Holdings and Megaworld will pay the vaccines, of which half will be donated to the government.The other half will be used to inoculate the private sector&#x27;s employees, said Galvez. The private firms will prioritize those considered poor such as laborers, truck drivers, and security guards, he added.Presidential adviser on entrepreneurship Joey Concepcion had said they were looking into procuring more vaccines of up to 3 million doses.<ul class="op-related-articles">	<li><a href="https://news.abs-cbn.com/business/11/26/20/private-sector-to-procure-up-to-3-million-vaccine-doses-says-presidential-adviser">Private sector to procure up to 3 million vaccine doses, says presidential adviser</a></li></ul>Amid fears the vaccines are rushed and may carry potential side effects, Galvez, who also serves as the pandemic response chief implementer, assured the public the government would not be cutting corners to solve the pandemic.He said the vaccines would be first administered en masse to their country of origin.&quot;Bago tayo maturukan, may mass vaccination na naganap,&quot; he added.(Before we get vaccinated, there would be mass vaccination [in other countries.)As of Thursday, the Philippines has tallied 424,297 coronavirus cases, of which 8,242 deaths were linked to the disease. Some 387,266 patients have recovered from COVID-19 while 28,789 have yet to recover.<figure class="op-interactive"><iframe src="https://www.youtube.com/embed/qQmhEinFlpE?enablejsapi=1"></iframe></figure><div class="iwantbar">Watch more in <a href="//www.iwantv.com.ph/">iWantv</a> or <a href="//tfc.tv/">TFC.tv</a></div>

The Philippines is looking into building a portfolio of potential vaccines against the novel coronavirus, an official spearheading the country's COVID-19 inoculation program said Friday, as it set to sign a supply deal of 2 million doses with British pharmaceutical firm AstraZeneca.

The Philippines is looking into building a portfolio of potential vaccines against the novel coronavirus, an official spearheading the country's COVID-19 inoculation program said Friday, as it set to sign a supply deal of 2 million doses with British pharmaceutical firm AstraZeneca.

Philippines eyes portfolio of potential vaccines vs COVID-19

News

Entertainment

Lifestyle

Sports

Metro.Style

More

Traffic

Manila

Horoscope

News

Philippines eyes portfolio of potential vaccines vs COVID-19

Davinci Maru,

ABS-CBN News

Published Nov 27, 2020 05:06 PM PHT

Read More:

Teleradyo

vaccine czar Carlito Galvez

Philippines portfolio COVID-19 vaccines

Philippines COVID-19 vaccine update

Philippines AstraZeneca COVID-19 vaccine

Philippines Pfizer COVID-19 vaccine

COVID-19

coronavirus disease 2019

COVID-19 vaccine

ABS-CBN is the leading media and entertainment company in the Philippines, offering quality content across TV, radio, digital, and film. Committed to public service and promoting Filipino values, ABS-CBN continues to inspire and connect audiences worldwide.

Corporate

Investors

Governance

International Distribution

Corporate

Governance

Investors

International Distribution

NPC Seal of Registration

Privacy Policy

AI Policy

Terms of Service

Advertise with Us

© 2025 ABS-CBN Corporation. All Rights Reserved.

NPC Seal of Registration

Privacy Policy

Terms of Service

AI Policy

Advertise with Us

© 2025 ABS-CBN Corporation. All Rights Reserved.

NPC Seal of Registration

Privacy Policy

Terms of Service

AI Policy

Advertise with Us

© 2025 ABS-CBN Corporation. All Rights Reserved.